drugset / Trial / NCT00536770
A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of an investigational study drug DN-101 (calcitriol) when given in combination with gemcitabine ± erlotinib in the treatment of pancreatic cancer.
Timeline
- Start
- 2007-09
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “DSMB”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcitriol | Small molecule | — | — |
| Comparator | Erlotinib | Small molecule | — | — |
| Comparator | Gemcitabine | Small molecule | — | — |